Nathan D. Jorgensen

Business address
C/O Vor Biopharma Inc., 100 Cambridgepark Drive, Suite 400, Cambridge, MA, 02140
Top holdings (ownership)
VYGR and VOR
Get insider transactions for this reporting owner
Nathan D. Jorgensen has filed 22 SEC EDGAR filings since 04 Feb 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT 07 Oct 2025 03 Oct 2025 001-37625
144 Open Document Open Filing 03 Oct 2025
4 Open Document Open Filing OWNERSHIP DOCUMENT 24 Feb 2025 21 Feb 2025 001-37625
4 Open Document Open Filing OWNERSHIP DOCUMENT 02 Oct 2024 01 Oct 2024 001-37625
144 Open Document Open Filing 19 Jul 2024
4 Open Document Open Filing OWNERSHIP DOCUMENT 09 Jul 2024 08 Jul 2024 001-37625
3 Open Document Open Filing OWNERSHIP DOCUMENT 09 Jul 2024 08 Jul 2024 001-37625
4 Open Document Open Filing 07 May 2024 06 May 2024 001-39979
4 Open Document Open Filing 03 May 2024 01 May 2024 001-39979
4 Open Document Open Filing 05 Mar 2024 01 Mar 2024 001-39979
4 Open Document Open Filing 08 Feb 2024 06 Feb 2024 001-39979
4 Open Document Open Filing 31 Jan 2024 29 Jan 2024 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 08 Nov 2023 06 Nov 2023 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 06 Sep 2023 01 Sep 2023 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 09 Aug 2023 07 Aug 2023 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 10 May 2023 08 May 2023 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2023 01 Mar 2023 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 08 Feb 2023 06 Feb 2023 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 06 Sep 2022 01 Sep 2022 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 03 Feb 2022 01 Feb 2022 001-39979
4 Open Document Open Filing FORM 4 SUBMISSION 09 Feb 2021 09 Feb 2021 001-39979
3 Open Document Open Filing FORM 3 SUBMISSION 04 Feb 2021 04 Feb 2021 001-39979